Variant report
Variant | esv3313009 |
---|---|
Chromosome Location | chr16:76598907-76601569 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs533363833 | chr16:76598914-76598915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs543992073 | chr16:76598930-76598931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs563481240 | chr16:76598949-76598950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs529332064 | chr16:76598982-76598983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs35948950 | chr16:76598992-76598993 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs141412115 | chr16:76599039-76599040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs9930492 | chr16:76599110-76599111 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs569630326 | chr16:76599141-76599142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs150915226 | chr16:76599146-76599147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs183322518 | chr16:76599188-76599189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs556387360 | chr16:76599191-76599192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs139403100 | chr16:76599209-76599210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs4539627 | chr16:76599222-76599223 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs150043718 | chr16:76599228-76599229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572078254 | chr16:76599231-76599232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs4594276 | chr16:76599235-76599236 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs558212445 | chr16:76599238-76599239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs146599141 | chr16:76599282-76599283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187477179 | chr16:76599299-76599300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs4630579 | chr16:76599303-76599304 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs139220944 | chr16:76599304-76599305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs4499263 | chr16:76599347-76599348 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs559382401 | chr16:76599389-76599390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs532740987 | chr16:76599431-76599432 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs549383207 | chr16:76599441-76599442 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs528481693 | chr16:76599447-76599448 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs192433742 | chr16:76599469-76599470 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs73628412 | chr16:76599499-76599500 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs370943194 | chr16:76599512-76599513 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs554616828 | chr16:76599538-76599539 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs533243671 | chr16:76599554-76599555 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs550069419 | chr16:76599557-76599558 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs569879004 | chr16:76599584-76599585 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs535602578 | chr16:76599681-76599682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs114734916 | chr16:76599703-76599704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs183426240 | chr16:76599734-76599735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs565763683 | chr16:76599736-76599737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs534361161 | chr16:76599746-76599747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs557719616 | chr16:76599790-76599791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs144020517 | chr16:76599796-76599797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21806811 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 19156837 | CNVD |
Acute myeloid leukemia | 17377590 | CNVD |
Breast cancer | 20409316 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Lung cancer | 24585490 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:76554600-76599400 | Weak transcription | Brain Inferior Temporal Lobe | brain |
2 | chr16:76588000-76599400 | Weak transcription | Brain Cingulate Gyrus | brain |
3 | chr16:76599400-76599600 | Enhancers | Brain Cingulate Gyrus | brain |
4 | chr16:76599400-76599600 | Active TSS | Brain Inferior Temporal Lobe | brain |
5 | chr16:76599400-76599800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |